NCT04351763View on ClinicalTrials.gov

Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

804

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

May 25, 2021

Study Completion Date

June 5, 2021

Conditions
COVID-19
Interventions
DRUG

Amiodarone

Ion channel blocker

DRUG

Verapamil

Ion channel blocker

Trial Locations (1)

Unknown

Nicolaus Copernicus University, Bydgoszcz

All Listed Sponsors
lead

Nicolaus Copernicus University

OTHER

NCT04351763 - Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms | Biotech Hunter | Biotech Hunter